Hand-foot-genital syndrome

From WikiMD's Medical Encyclopedia

(Redirected from Hand foot genital syndrome)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Hand-foot-genital syndrome
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Limb malformation, urinary tract abnormalities, genital abnormalities
Complications Urinary tract infections, infertility
Onset Congenital
Duration Lifelong
Types N/A
Causes Mutations in the HOXA13 gene
Risks Family history
Diagnosis Clinical diagnosis, genetic testing
Differential diagnosis Urofacial syndrome, VACTERL association
Prevention N/A
Treatment Surgical intervention, supportive care
Medication N/A
Prognosis Variable, depending on severity
Frequency Rare
Deaths N/A


A rare genetic disorder affecting limb and urogenital development


Hand-foot-genital syndrome (HFGS) is a rare autosomal dominant genetic disorder characterized by limb malformations and urogenital anomalies. It is caused by mutations in the HOXA13 gene, which plays a crucial role in the development of the limbs and the urogenital tract.

Clinical Features[edit]

Individuals with hand-foot-genital syndrome typically present with a combination of limb and urogenital abnormalities. The severity and specific manifestations can vary among affected individuals.

Limb Abnormalities[edit]

- Hand Malformations: Patients often exhibit brachydactyly, which is the shortening of the fingers and toes. The thumbs may be particularly affected, showing hypoplasia or underdevelopment. - Foot Malformations: Similar to the hands, the feet may also show brachydactyly. There may be additional anomalies such as clubfoot or other positional deformities.

Urogenital Anomalies[edit]

- Females: Affected females may have uterine didelphys, a condition where the uterus is duplicated, or other Müllerian duct anomalies. - Males: Affected males may present with hypospadias, where the opening of the urethra is on the underside of the penis rather than at the tip.

Genetics[edit]

Hand-foot-genital syndrome is caused by mutations in the HOXA13 gene, which is located on chromosome 7p15.2. This gene is part of the homeobox gene family, which is involved in regulating patterns of anatomical development (morphogenesis) in animals, fungi, and plants. The condition is inherited in an autosomal dominant manner, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. This also implies that an affected individual has a 50% chance of passing the mutation to their offspring.

Diagnosis[edit]

Diagnosis of hand-foot-genital syndrome is primarily based on clinical evaluation and the identification of characteristic physical features. Genetic testing can confirm the diagnosis by identifying mutations in the HOXA13 gene.

Management[edit]

Management of hand-foot-genital syndrome is symptomatic and supportive. It may involve: - Orthopedic Interventions: Surgical correction of limb deformities may be necessary to improve function and mobility. - Urological and Gynecological Care: Management of urogenital anomalies may require surgical intervention and ongoing medical care. - Genetic Counseling: Families may benefit from genetic counseling to understand the inheritance pattern and implications for family planning.

Prognosis[edit]

The prognosis for individuals with hand-foot-genital syndrome varies depending on the severity of the symptoms and the presence of any associated complications. With appropriate management, many individuals can lead relatively normal lives.

See also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.